Contrasting effects of ultraviolet-A and ultraviolet-B exposure on induction of contact sensitivity in human skin

Clinical and Experimental Immunology

Volumn 107, Issue 3, 1997, Pages 585-588

  Skov, L ^a,d   Hansen, H ^a   Barker, J N W N ^b   Simon, J C ^c   Baadsgaard, O ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b ST THOMAS HOSPITAL   (United Kingdom)

^c UNIVERSITY OF FREIBURG   (Germany)

^d GENTOFTE UNIVERSITY HOSPITAL   (Denmark)

Author keywords

DPCP; Immunosuppression; Photoimmunology; Skin cancer

Indexed keywords

ALLERGEN; DIPHENCYPRONE; TUMOR ANTIGEN;

ADULT; ARTICLE; CARCINOGENICITY; CLINICAL TRIAL; CONTACT SENSITIVITY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; HUMAN; HUMAN EXPERIMENT; IMMUNIZATION; NORMAL HUMAN; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SKIN CANCER; ULTRAVIOLET A RADIATION; ULTRAVIOLET B RADIATION;

EID: 0031041280     PISSN: 00099104     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2249.1997.d01-944.x     Document Type: Article

References (17)

1. Kripke ML. Antigenicity of murine skin tumors induced by ultraviolet light. J Natl Cancer Inst 1974; 53:1333-6.
2. Fisher MS, Kripke ML. Systemic alteration induced in mice by ultraviolet light irradiation and its relationship to ultraviolet carcinogenesis. Proc Natl Acad Sci USA 1977; 74:1688-92.
3. Fisher MS, Kripke ML. Suppressor T lymphocytes control the development of primary skin cancers in ultraviolet-irradiated mice. Science 1982; 216:1133-4.
4. Ullrich SE, Kripke ML. Mechanisms in the suppression of tumor rejection produced in mice by repeated UV irradiation. J Immunol 1984; 133:2786-90.
5. Toews GB, Bergstresser PR, Streilein JW. Epidermal Langerhans cell density determines whether contact hypersensitivity or unresponsiveness follows skin painting with DNFB. J Immunol 1980; 124:445-53.
6. Yoshikawa T, Rae V, Bruins Slot W, van den Berg JW, Taylor JR, Streilein JW. Susceptibility to effects of UVB radiation on induction of contact hypersensitivity as a risk factor for skin cancer in humans. J Invest Dermatol 1990; 95:530-6.
7. + epidermal macrophage induction, and Langerhans cell depletion. Proc Natl Acad Sci USA 1992; 89:8497-501.
8. Krutmann J. Ultraviolet A1 radiation-induced immunomodulation; high-dose UVA1 therapy of atopic dermatitis. In: Krutmann J, Elmets CA, eds. Photoimmunology. Oxford: Blackwell Science, 1995:246-56.
9. Friedmann PS, Moss C, Shuster S, Simpson JM. Quantitative relationships between sensitizing dose of DNCB and reactivity in normal subjects. Clin Exp Immunol 1983; 53:709-15.
10. Baadsgaard O, Lisby S, Wantzin GL, Wulf HC, Cooper KD. Rapid recovery of Langerhans cell alloreactivity, without induction of autoreactivity, after in vivo ultraviolet A, but not ultraviolet B exposure of human skin. J Immunol 1989; 142:4213-8.
11. Friedmann PS, White SI, Parker S, Moss C, Matthews JN. Antigenic stimulation during ultraviolet therapy in man does not result in immunological tolerance. Clin Exp Immunol 1989; 76:68-72.
12. Whitmore SE, Morison WL. Prevention of UVB-induced immunosuppression in humans by a high sun protection factor sunscreen. Arch Dermatol 1995; 131:1128-33.
13. + cells that enhance epidermal alloantigen presentation. J Immunol 1985; 134:129-37.
14. + antigen-presenting cells in human epidermis. J Invest Dermatol 1987; 89:113-8.
15. + macrophages that infiltrate human epidermis after in vivo ultraviolet exposure potently produce IL-10 and represent the major secretory source of epidermal IL-10 protein. J Immunol 1994; 153:5256-64.
16. Fiorentino DF, Bond MW, Mosmann TR. Two types of mouse T helper cell. IV. Th2 clones secrete a factor that inhibits cytokine production by Th1 clones. J Exp Med 1989; 170:2081-95.
17. Lombardi G, Sidhu S, Batchelor R, Lechler R. Anergic T cells as suppressor cells in vitro. Science 1994; 264:1587-9.